吉林大学学报(医学版) ›› 2016, Vol. 42 ›› Issue (05): 932-936.doi: 10.13481/j.1671-587x.20160518

• 临床研究 • 上一篇    下一篇

Disabled-1在人乳腺癌细胞中的表达及其对细胞周期的影响

曹让娟1, 李凯2, 邢琬莹3, 王悦书1, 于维1, 吴广智1, 崔树森1, 李强1   

  1. 1. 吉林大学中日联谊医院手外科, 吉林 长春 130033;
    2. 吉林大学中日联谊医院麻醉科, 吉林 长春 130033;
    3. 吉林大学中日联谊医院乳腺外科, 吉林 长春 130033
  • 收稿日期:2016-04-12 出版日期:2016-09-28 发布日期:2016-09-29
  • 通讯作者: 李强,主治医师(Tel:0431-89876961,E-mail:alex334@163.com) E-mail:alex334@163.com
  • 作者简介:曹让娟(1987-),女,重庆市人,讲师,医学博士,主要从事乳腺癌发生发展及周围神经损伤后再生等方面的研究。
  • 基金资助:

    国家自然科学基金资助课题(81502516);吉林省科技厅科技发展计划项目资助课题(20160101077JC);吉林省科技厅医药产业发展引导资金项目资助课题(20150311069YY);吉林大学白求恩计划项目青年基金资助课题(2015429)

Expression of Disabled-1 in human breast cancer cells and its role in cell cycle

CAO Rangjuan1, LI Kai2, XING Wanying3, WANG Yueshu1, YU Wei1, WU Guangzhi1, CUI Shusen1, LI Qiang1   

  1. 1. Department of Hand Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033;
    2. Department of Anesthesiology, China-Japan Union Hospital, Jilin University, Changchun 130033;
    3. Department of Breast Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China
  • Received:2016-04-12 Online:2016-09-28 Published:2016-09-29

摘要:

目的:探讨Disabled-1(Dab1)基因在乳腺上皮细胞及乳腺癌细胞中的表达情况,并阐明Dab1对乳腺癌细胞周期的影响。方法:体外培养永生化的乳腺上皮细胞MCF-10A及乳腺癌细胞MCF-7、BT-549和MDA-MB-231,实时荧光定量(Real-time PCR)法检测MCF-10A、MCF-7、BT-549和MDA-MB-231细胞中Dab1 mRNA的表达水平,Western blotting法检测Dab1蛋白的表达水平。取对数生长期的BT-549细胞,分为对照组、转染pKH3组和转染pKH3-Dab1组,采用流式细胞术检测各组细胞周期的变化情况。结果:Real-time PCR法检测,与MCF-10A细胞(0.998±0.020)比较,乳腺癌细胞MCF-7(0.504±0.037)、BT-549(0.302±0.027)和MDA-MB-231(0.330±0.031)中Dab1 mRNA相对表达水平明显下降(P<0.05)。Western blotting法检测,与MCF-10A细胞(0.227±0.021)比较,乳腺癌细胞MCF-7(0.134±0.014)、BT-549(0.076±0.01)和MDA-MB-231(0.074±0.005)中Dab1蛋白表达水平明显下调(P<0.05)。流式细胞术检测,与对照组和转染pKH3组比较,转染pHK3-Dab1组BT-549细胞出现细胞周期G1期阻滞。结论:Dab1在体外培养乳腺癌细胞系中表达下调,Dab1过表达可阻滞乳腺癌细胞G1细胞周期进展。

关键词: Dab1基因, 人乳腺癌细胞, 细胞周期, G1期阻滞

Abstract:

Objective: To explore the expressions of Disabled-1(Dab1) in human breast epithelial cells and breast cancer cells, and to clarify its role in cell cycle. Methods: Real-time PCR was used to analyze the Dab1 mRNA expressions in breast epithelial cells MCF-10A and breast cancer cells MCF-7, BT-549, and MDA-MB-231. The Dab1 protein expressions in those cells were tested by Western blotting method. The BT-549 cells at logarithmic growth phase were divided into control, pKH3, and pKH3-Dab1 groups; the cell cycle was investigated by flow cytometry. Results:The Real-time PCR results showed that the Dab1 mRNA expression levels in MCF-7 cells (0.504±0.037), BT-549 cells (0.302±0.027), and MDA-MB-231 cells (0.330±0.031) were reduced compared with MCF-10A cells (0.998±0.020) (P<0.05). The Western blotting results showed that the Dab1 protein expression levels in breast cancer cells MCF-7 (0.134±0.014), BT-549 (0.076±0.01), and MDA-MB-231 (0.074±0.005) were reduced compared with MCF-10A cells (0.227±0.021) (P<0.05). Compared with control group and pKH3 group, the cell cycle in pKH3-Dab1 group was inhibited at G1 phase detected by flow cytometry analysis. Conclusion: The expression of Dab1 is down-regulated in breast cancer cells, and the over-expression of Dab1 can inhibit the cell cycle at G1 phase.

Key words: Dab1, human breast cancer cell, cell cycle, G1 phase inhibition

中图分类号: 

  • R730.2